467 related articles for article (PubMed ID: 16984993)
1. Clinical review: Controversies regarding transdermal androgen therapy in postmenopausal women.
Basaria S; Dobs AS
J Clin Endocrinol Metab; 2006 Dec; 91(12):4743-52. PubMed ID: 16984993
[TBL] [Abstract][Full Text] [Related]
2. The role of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Krapf JM; Simon JA
Maturitas; 2009 Jul; 63(3):213-9. PubMed ID: 19487090
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Davis SR; van der Mooren MJ; van Lunsen RH; Lopes P; Ribot C; Rees M; Moufarege A; Rodenberg C; Buch A; Purdie DW
Menopause; 2006; 13(3):387-96. PubMed ID: 16735935
[TBL] [Abstract][Full Text] [Related]
4. Testosterone therapy for postmenopausal women: efficacy and safety.
Somboonporn W
Semin Reprod Med; 2006 Apr; 24(2):115-24. PubMed ID: 16633985
[TBL] [Abstract][Full Text] [Related]
5. Testosterone treatment for hypoactive sexual desire disorder in postmenopausal women.
Kingsberg S
J Sex Med; 2007 Mar; 4 Suppl 3():227-34. PubMed ID: 17394595
[TBL] [Abstract][Full Text] [Related]
6. Androgen replacement for women.
Basson R
Can Fam Physician; 1999 Sep; 45():2100-7. PubMed ID: 10509222
[TBL] [Abstract][Full Text] [Related]
7. Testosterone therapy in women: a review.
Bolour S; Braunstein G
Int J Impot Res; 2005; 17(5):399-408. PubMed ID: 15889125
[TBL] [Abstract][Full Text] [Related]
8. Testosterone patch increases sexual activity and desire in surgically menopausal women with hypoactive sexual desire disorder.
Simon J; Braunstein G; Nachtigall L; Utian W; Katz M; Miller S; Waldbaum A; Bouchard C; Derzko C; Buch A; Rodenberg C; Lucas J; Davis S
J Clin Endocrinol Metab; 2005 Sep; 90(9):5226-33. PubMed ID: 16014407
[TBL] [Abstract][Full Text] [Related]
9. Testosterone for low libido in postmenopausal women not taking estrogen.
Davis SR; Moreau M; Kroll R; Bouchard C; Panay N; Gass M; Braunstein GD; Hirschberg AL; Rodenberg C; Pack S; Koch H; Moufarege A; Studd J;
N Engl J Med; 2008 Nov; 359(19):2005-17. PubMed ID: 18987368
[TBL] [Abstract][Full Text] [Related]
10. Transdermal testosterone for women: a new physiological approach for androgen therapy.
Mazer NA; Shifren JL
Obstet Gynecol Surv; 2003 Jul; 58(7):489-500. PubMed ID: 12832941
[TBL] [Abstract][Full Text] [Related]
11. The role of androgens in female sexual dysfunction.
Shifren JL
Mayo Clin Proc; 2004 Apr; 79(4 Suppl):S19-24. PubMed ID: 15065634
[TBL] [Abstract][Full Text] [Related]
12. The current outlook for testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Kingsberg SA; Simon JA; Goldstein I
J Sex Med; 2008 Sep; 5 Suppl 4():182-93; quiz 193. PubMed ID: 18783534
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of the clinical relevance of benefits associated with transdermal testosterone treatment in postmenopausal women with hypoactive sexual desire disorder.
Kingsberg S; Shifren J; Wekselman K; Rodenberg C; Koochaki P; Derogatis L
J Sex Med; 2007 Jul; 4(4 Pt 1):1001-8. PubMed ID: 17627745
[TBL] [Abstract][Full Text] [Related]
14. Androgen therapy in women: for whom and when.
Pluchino N; Carmignani A; Cubeddu A; Santoro A; Cela V; Errasti T
Arch Gynecol Obstet; 2013 Oct; 288(4):731-7. PubMed ID: 23912530
[TBL] [Abstract][Full Text] [Related]
15. Testosterone therapy for sexual dysfunction in postmenopausal women.
Hubayter Z; Simon JA
Climacteric; 2008 Jun; 11(3):181-91. PubMed ID: 18568783
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and safety of testosterone in the management of hypoactive sexual desire disorder in postmenopausal women.
Davis SR; Braunstein GD
J Sex Med; 2012 Apr; 9(4):1134-48. PubMed ID: 22304681
[TBL] [Abstract][Full Text] [Related]
17. Testosterone for peri- and postmenopausal women.
Somboonporn W; Davis S; Seif MW; Bell R
Cochrane Database Syst Rev; 2005 Oct; (4):CD004509. PubMed ID: 16235365
[TBL] [Abstract][Full Text] [Related]
18. The effects of compounded bioidentical transdermal hormone therapy on hemostatic, inflammatory, immune factors; cardiovascular biomarkers; quality-of-life measures; and health outcomes in perimenopausal and postmenopausal women.
Stephenson K; Neuenschwander PF; Kurdowska AK
Int J Pharm Compd; 2013; 17(1):74-85. PubMed ID: 23627249
[TBL] [Abstract][Full Text] [Related]
19. Androgen Therapy in Women.
Vegunta S; Kling JM; Kapoor E
J Womens Health (Larchmt); 2020 Jan; 29(1):57-64. PubMed ID: 31687883
[TBL] [Abstract][Full Text] [Related]
20. Safety and efficacy of a testosterone patch for the treatment of hypoactive sexual desire disorder in surgically menopausal women: a randomized, placebo-controlled trial.
Braunstein GD; Sundwall DA; Katz M; Shifren JL; Buster JE; Simon JA; Bachman G; Aguirre OA; Lucas JD; Rodenberg C; Buch A; Watts NB
Arch Intern Med; 2005 Jul; 165(14):1582-9. PubMed ID: 16043675
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
